[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100646317":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":18,"responsibleParty":34,"collaborators":38,"id":44,"slug":45,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":10,"eligibilityCriteria":50,"healthyVolunteers":46,"sex":51,"minAge":52,"maxAge":10,"enrollmentInfo":53,"targetDuration":56,"studyType":57,"phases":10,"briefSummary":58,"conditions":59,"keywords":60,"overallStatus":65,"whyStopped":10,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"University of Barcelona","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Peri-implantitis",null,"Inclusion Criteria Adult patients (≥18 years old) diagnosed with peri-implantitis according to the definition established by the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions (Berglundh et al., 2018).\n\nImplants presenting bleeding on probing and\u002For suppuration, increased probing depth, and progressive bone loss compared with previous records. When previous records are unavailable, implants will be included if they present bleeding and\u002For suppuration on gentle probing, probing depth ≥ 6 mm, and a bone level ≥ 3 mm apical to the most coronal portion of the implant's rough surface.\n\nIn patients requiring multiple surgical interventions, only the first surgical procedure will be included in the study.",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Octavi Camps Font, DDS MS PhD","CONTACT","+34 934 024 269","ocamps@ub.edu",[19],{"facility":20,"status":10,"city":21,"state":22,"zip":23,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"Octavi Camps","L'Hospitalet de Llobregat","Barcelona","08907","Spain","ES",{"type":27,"coordinates":28},"Point",[29,30],2.10028,41.35967,{"lat":30,"lon":29},[33],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},{"type":35,"investigatorFullName":36,"investigatorTitle":37,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Octavi Camps-Font","Associate Professor",[39,41],{"name":40,"class":6},"Universitat Internacional de Catalunya",{"name":42,"class":43},"Universitat de Valencia, España","UNKNOWN","100646317","patient-perspectives-throughout-peri-implantitis-treatment-100646317",false,"NCT07694323","Patient Perspectives Throughout Peri-Implantitis Treatment","Patient-Centered Outcomes Throughout Peri-Implantitis Therapy: A Multicenter Prospective Observational Study","Inclusion Criteria:\n\n* Adults (≥18 years) diagnosed with peri-implantitis according to the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions (Berglundh et al., 2018).\n* Implants presenting bleeding on probing (BoP) and\u002For suppuration on probing (SoP), increased probing depth, and progressive bone loss compared with previous records.\n\nWhen previous records are unavailable, implants will be included if they present bleeding and\u002For suppuration on gentle probing, probing depth ≥6 mm, and a bone level ≥3 mm apical to the most coronal portion of the rough implant surface.\n\n\\- For patients requiring multiple peri-implantitis surgeries, only the first surgical intervention will be included.\n\nExclusion Criteria:\n\n* Patients who, following non-surgical peri-implantitis treatment, present ≤1 site with isolated bleeding on probing, no suppuration on probing, probing depths ≤5 mm, and no progressive bone loss compared with pretreatment bone levels.\n* Contraindications to surgical peri-implantitis treatment, including plaque index \\>20% and bleeding on probing \\>10%.\n* Previous radiotherapy to the head and neck region.\n* Uncontrolled diabetes mellitus\u002Fhyperglycaemia (HbA1c \\>7%).\n* Pregnancy or breastfeeding at the time of enrollment.\n* Alcohol or substance abuse.\n* Previous surgical treatment of peri-implantitis at the same implant.\n* Inability to complete the postoperative pain assessment (VAS) or the oral health-related quality of life (OHRQoL) questionnaires.","ALL","18 Years",{"count":54,"type":55},45,"ESTIMATED","1 Year","OBSERVATIONAL","To evaluate longitudinal changes in oral health-related quality of life (OHRQoL) and other patient-reported outcomes (PROMs) throughout the different stages of peri-implantitis therapy, including diagnosis, non-surgical treatment, surgical treatment, and 6-month follow-up. Secondarily, to explore the influence of clinical, implant-related, and surgical factors on patient-reported outcomes and treatment experience.",[9],[9,61,62,63,64],"Patient-centered outcomes","Oral health-related quality of life","Dental implants","Patient satisfaction","NOT_YET_RECRUITING","2026-07-07",{"date":68,"type":69},"2026-07-09","ACTUAL",{"date":71,"type":55},"2026-09-03",{"date":73,"type":55},"2028-03-30",{"name":5,"class":6},1]